An observational study in Ischemic Stroke, sponsored by Ruhr University of Bochum. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-04-30.
Sponsored by Ruhr University of Bochum · Observational
The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's enrollment of 159 is close to the median of 160 across 1,692 observational studies indexed under Stroke.
Browse Stroke studies →Ruhr University of Bochum is the lead sponsor of 124 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with an acute ischemic stroke admitted to our stroke unit and treated with clopidogrel
Exclusion Criteria:
Determing cardiovascular risk factors or medication on clopidogrel response rates after an acute ischemic stroke
Result of platelet function test
Aggregometry result of antiplatelet therapy
Time frame: one day
This study is completed, as verified in Apr 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ruhr University of Bochum